RESUMO
Biomedical imaging allows in vivo studies of organisms, providing valuable information of biological processes at both cellular and tissue levels. Nanodiamonds have recently emerged as a new type of probe for fluorescence imaging and contrast agent for magnetic resonance and photoacoustic imaging. Composed of sp3-carbon atoms, diamond is chemically inert and inherently biocompatible. Uniquely, its matrix can host a variety of optically and magnetically active defects suited for bioimaging applications. Since the first production of fluorescent nanodiamonds in 2005, a large number of experiments have demonstrated that fluorescent nanodiamonds are useful as photostable markers and nanoscale sensors in living cells and organisms. In this review, we focus our discussion on the recent advancements of nanodiamond-enabled biomedical imaging for preclinical applications.